G protein-coupled receptors (GPCRs) are responsible for the majority of cellular responses to hormones and neurotransmitters as well as the senses of sight, olfaction and taste. The paradigm of GPCR signalling is the activation of a heterotrimeric GTP binding protein (G protein) by an agonist-occupied receptor. The b 2 adrenergic receptor (b 2 AR) activation of Gs, the stimulatory G protein for adenylyl cyclase, has long been a model system for GPCR signalling. Here we present the crystal structure of the active state ternary complex composed of agonist-occupied monomeric b 2 AR and nucleotide-free Gs heterotrimer. The principal interactions between the b 2 AR and Gs involve the amino-and carboxy-terminal a-helices of Gs, with conformational changes propagating to the nucleotide-binding pocket. The largest conformational changes in the b 2 AR include a 14 Å outward movement at the cytoplasmic end of transmembrane segment 6 (TM6) and an a-helical extension of the cytoplasmic end of TM5. The most surprising observation is a major displacement of the a-helical domain of Gas relative to the Ras-like GTPase domain. This crystal structure represents the first high-resolution view of transmembrane signalling by a GPCR.
Introduction
The b 2 adrenergic receptor (b 2 AR) has been a model system for the large and diverse family of G protein-coupled receptors (GPCRs) for over 40 years. It was one of the first GPCRs to be characterized by radioligand binding, and it was the first neurotransmitter receptor to be cloned 1 and structurally determined by crystallography 2, 3 . The b 2 AR was initially identified based on its physiological and pharmacological properties, but it was not known if receptors and G proteins were separate entities, or parts of the same protein 4 . Subsequent biochemical studies led to the isolation and purification of functional b 2 AR and Gs, the stimulatory G protein that activates adenylyl cyclase, and the reconstitution of this signalling complex in phospholipid vesicles 5, 6 . The cooperative interactions of b 2 AR and Gs observed in ligand binding assays formed the foundation of the ternary complex model of GPCR activation 7, 8 . In the ternary complex consisting of agonist, receptor and G protein, the affinity of the receptor for agonist is enhanced and the specificity of the G protein for guanine nucleotides changes in favour of GTP over GDP. The GPCR field has evolved markedly since these initial studies. Isolation of the genes and cDNAs for the b 2 AR and other GPCRs using protein sequencing and expression cloning led to the expansion of the family by homology cloning. More recently, sequencing of the human genome led to the identification of over 800 GPCR genes 9 . Experimental tools for identifying protein-protein interactions and for expression and silencing of genes have revealed a complex network of cellular signalling and regulatory pathways including G protein-independent activation of cytosolic kinases 10, 11 . Nevertheless, the b 2 AR continues to be a relevant model for most aspects of GPCR pharmacology, signalling and regulation.
Notwithstanding the remarkable advances in this field, we still know relatively little about the structural basis for transmembrane signalling by GPCRs. Figure 1 shows the G protein cycle for the b 2 AR-Gs complex. Agonist binding to the b 2 AR promotes interactions with GDP-bound Gsabc heterotrimer, leading to the exchange of GDP for GTP, and the functional dissociation of Gs into Ga-GTP and Gbc subunits. The separate Ga-GTP and Gbc subunits can modulate the activity of different cellular effectors (channels, kinases or other enzymes). The intrinsic GTPase activity of Gas leads to hydrolysis of GTP to GDP and the reassociation of Ga-GDP and Gbc subunits, and the termination of signalling. The active state of a GPCR can be defined as that conformation that couples to and stabilizes a nucleotide-free G protein. In this agonist-b 2 AR-Gs ternary complex, Gs has a higher affinity for GTP than GDP, and the b 2 AR has an approximately 100-fold higher affinity for agonists than does b 2 AR alone. In an effort to understand the structural basis for GPCR signalling, we crystallized the b 2 AR-Gs complex.
Crystallization of the b 2 AR-Gs complex
The first challenge for crystallogenesis was to prepare a stable b 2 AR-Gs complex in detergent solution. The b 2 AR and Gs couple efficiently in lipid bilayers, but not in detergents used to solubilize and purify these proteins. We found that a relatively stable b 2 AR-Gs complex could be prepared by mixing purified GDP-Gs (approximately 100 mM final concentration) with a molar excess of purified b 2 AR bound to a high affinity agonist (BI-167107, Boehringer Ingelheim) 12 in dodecylmaltoside solution. Apyrase, a non-selective purine pyrophosphatase, was added to hydrolyse GDP released from Gs on forming a complex with the b 2 AR. Removal of GDP was essential because both GDP and GTP can disrupt the high-affinity interaction between b 2 AR and Gs ( Supplementary Fig. 1a ). The complex was subsequently purified by sequential antibody affinity chromatography and size-exclusion chromatography. The stability of the complex was enhanced by exchanging it into a recently developed maltose neopentyl glycol detergent MNG-3 (NG310, Anatrace) 13 . The complex could be incubated at room temperature for 24 h without any noticeable degradation; however, initial efforts to crystallize the complex using sparse matrix screens in detergent micelles, bicelles and lipidic cubic phase (LCP) failed.
To further assess the quality of the complex, we analysed the protein by single particle electron microscopy 34 . The results confirmed that the complex was monodisperse, but revealed two potential problems for obtaining diffraction of quality crystals. First, the detergent used to stabilize the complex formed a large micelle, leaving little polar surface on the extracellular side of the b 2 AR-Gs complex for the formation of crystal lattice contacts. Our initial approach to this problem, which was to generate antibodies to the extracellular surface, was not successful. As an alternative approach, we replaced the unstructured amino terminus of the b 2 AR with T4 lysozyme (T4L). We previously used T4L to facilitate crystallogenesis of the inactive b 2 AR by inserting T4L between the cytoplasmic ends of TM5 and TM6 (ref. 3) . Several different amino-terminal fusion proteins were prepared and single particle electron microscopy was used to identify a fusion with a relatively fixed orientation of T4L in relation to the b 2 AR.
The second problem revealed by single particle electron microscopy analysis was increased variability in the positioning of the a-helical component of the Gas subunit. Gas consists of two domains, the Ras-like GTPase domain (GasRas), which interacts with the b 2 AR and the Gb subunit, and the a-helical domain (GasAH) 14 . The interface of the two Gas subdomains forms the nucleotide-binding pocket (Fig. 1) , and electron microscopy two-dimensional (2D) averages and three-dimensional (3D) reconstructions show that in the absence of guanine nucleotide, GasAH has a variable position relative to the complex of T4L-b 2 AR-GasRas-Gbc ( Fig. 1b) 34 .
We attributed the variable position of GasAH to the empty nucleotide-binding pocket. However, as noted above both GDP and non-hydrolysable GTP analogues disrupt the b 2 AR-Gs complex (Supplementary Fig. 1 ). The addition of the pyrophosphate analogue phosphonoformate (foscarnet) led to a significant increase in stabilization of GasAH as determined by electron microscopy analysis of the detergent-solubilized complex 34 . Crystallization trials were carried out in LCP using a modified monolein (7.7 MAG, see Methods) designed to accommodate the large hydrophilic component of the T4L-b 2 AR-Gs complex 15 . Although we were able to obtain small crystals that diffracted to 7 Å , we were unable to improve their quality through the use of additives and other modifications.
In an effort to generate an antibody that would further stabilize the complex and facilitate crystallogenesis, we crosslinked b 2 AR and the Gs heterotrimer with a small, homobifunctional amine-reactive crosslinker and used this stabilized complex to immunize llamas. Llamas and other camelids produce antibodies devoid of light chains. The single domain antigen binding fragments of these heavy-chain-only antibodies, known as nanobodies, are small (15 kDa), rigid, and are easily cloned and expressed in Escherichia coli (Methods) 16 . We obtained a nanobody (Nb35) that binds to the complex and prevents dissociation of the complex by GTPcS ( Supplementary Fig. 1 ). The T4L-b 2 AR-Gs-Nb35 complex was used to obtain crystals that grew to 250 mm ( Supplementary Fig. 2 ) in LCP (7.7 MAG) and diffracted to 2.9 Å . A 3.2 Å data set was obtained from 20 crystals and the structure was determined by molecular replacement (Methods).
The b 2 AR-Gs complex crystallized in primitive monoclinic space group P2 1 , with a single complex in each asymmetric unit. Figure 2a shows the crystallographic packing interactions. Complexes are arrayed in alternating aqueous and lipidic layers with lattice contacts formed almost exclusively between soluble components of the complex, leaving receptor molecules suspended between G protein layers and widely separated from one another in the plane of the membrane. Extensive lattice contacts are formed among all the soluble proteins, probably accounting for the strong overall diffraction and remarkably clear electron density for the G protein. Nb35 and T4L facilitated crystal formation. Nb35 packs at the interface of the Gb and Ga subunits, with the complementarity determining region (CDR) 1 interacting primarily with Gb and a long CDR3 loop interacting with both Gb and Ga subunits. The framework regions of Nb35 from one complex also interact with Ga subunits from two adjacent complexes. T4L is linked to the b 2 AR only through amino-terminal fusion, but packs against the amino terminus of the Gb subunit of one complex, the carboxy terminus of the Gc subunit of another complex, and the Ga subunit of yet another complex. Figure 2b shows the structure of the complete complex including T4L and Nb35, and Fig. 2c shows the b 2 AR-Gs complex alone.
Structure of the active-state b 2 AR
The b 2 AR-Gs structure provides the first high-resolution insight into the mechanism of signal transduction across the plasma membrane by a GPCR, and the structural basis for the functional properties of the ternary complex. Figure 3a and Ca 21 channels. The Gs heterotrimer reassembles from a and bc subunits following hydrolysis of GTP to GDP in the a subunit. b, The purified nucleotide-free b 2 AR-Gs protein complex maintained in detergent micelles. The Gas subunit consists of two domains, the Ras domain (aRas) and the a-helical domain (aAH). Both are involved in nucleotide binding. In the nucleotide-free state, the aAH domain has a variable position relative the aRas domain.
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carazolol-bound b 2 AR. The largest difference between the inactive and active structures is a 14 Å outward movement of TM6 when measured at the Ca carbon of E268. There is a smaller outward movement and extension of the cytoplasmic end of the TM5 helix by 7 residues. A stretch of 26 amino acids in the third intracellular loop (ICL3) is disordered. Another notable difference between inactive and active structures is the second intracellular loop (ICL2), which forms an extended loop in the inactive b 2 AR structure and an a-helix in the b 2 AR-Gs complex. This helix is also observed in the b 2 AR-Nb80 structure (Fig. 3b ); however, it may not be a feature that is unique to the active state, because it is also observed in the inactive structure of the highly homologous avian b 1 AR (ref. 17 ). The quality of the electron density maps for the b 2 AR is highest at the b 2 AR-GasRas interface, and much weaker for the extracellular half. The extracellular half of the receptor is not stabilized by any packing interactions either laterally with adjacent receptors in the membrane or through the extracellular surface. Instead, the extracellular region is indirectly tethered to the well-packed soluble components by the amino-terminal fusion to T4 lysozyme ( Fig. 2a ). Given the flexible and dynamic nature of GPCRs, the absence of stabilizing packing interactions may lead to structural heterogeneity in the extracellular half of the receptor and, consequently, to the limited quality of the electron density maps. However, the overall structure of the b 2 AR in the T4L-b 2 AR-Gs complex is very similar to our recent active-state structure of b 2 AR stabilized by a G protein mimetic nanobody (Nb80) 12 . In the b 2 AR-Nb80 crystal, each receptor molecule has extensive packing interactions with adjacent receptors and the quality of the electron density maps for the agonist-bound b 2 AR in this complex is remarkably good for a 3.5 Å structure. Therefore, the b 2 AR-Nb80 structure allows us to confidently model BI-167107 here, and provide a more reliable view of the conformational rearrangements of amino acids around the ligand-binding pocket and between the ligand-binding pocket and the Gs-coupling interface 12 .
The overall root mean square deviation between the b 2 AR components in the b 2 AR-Gs and b 2 AR-Nb80 structures is approximately 0.6 Å , and they differ most at the cytoplasmic ends of transmembrane helices 5 and 6 where they interact with the different proteins ( Fig. 3b-d ).
The largest divergence is a 3 Å outward movement at the end of helix 6 in the b 2 AR-Gs complex. However, the differences between these two structures are very small at the level of the most highly conserved amino acids (E/DRY and NPxxY), which are located at the cytoplasmic ends of the transmembrane segments ( Fig. 3c, d ). These conserved sequences have been proposed to be important for activation or for maintaining the receptor in the inactive state 18 . Of these residues, only Arg 131 differs significantly between these two structures. In b 2 AR-Nb80 Arg 131 interacts with Nb80, whereas in the b 2 AR-Gs structure Arg 131 packs against Tyr 391 of Gas ( Supplementary Fig. 3 ). The high structural similarity is in agreement with the functional similarity of these two proteins. The b 2 AR-Nb80 complex shows the same high affinity for the agonist isoproterenol as does the b 2 AR-Gs complex 12 , consistent with high structural homology around the ligand binding pocket.
The active state of the b 2 AR is stabilized by extensive interactions with GasRas ( Fig. 4 ). There are no direct interactions with Gb or Gc subunits. The total buried surface of the b 2 AR-GasRas interface is 2,576 Å 2 (1,300 Å 2 for GasRas and 1,276 Å 2 for the b 2 AR). This interface is formed by ICL2, TM5 and TM6 of the b 2 AR, and by a5-helix, the aN-b1 junction, the top of the b3-strand, and the a4-helix of GasRas (see Supplementary Table 1 for specific interactions). Some of the b 2 AR sequences involved in this interaction have been shown to have a role in G protein coupling; however, there is no clear consensus sequence for Gs-coupling specificity when these segments are aligned with other GPCRs. Perhaps this is not surprising considering that the b 2 AR also couples to Gi and that many GPCRs couple to more than one G protein isoform. Of the 21 amino acids of Gs that are within 4 Å of the b 2 AR, only five are identical between Gs and Gi, and all of these complex. a, Lattice packing of the complex shows alternating layers of receptor and G protein within the crystal. Abundant contacts are formed among proteins within the aqueous layers. b, The overall structure of the asymmetric unit contents shows the b 2 AR (green) bound to an agonist (yellow spheres) and engaged in extensive interactions with Gas (orange). Gas together with Gb (cyan) and Gc (purple) constitute the heterotrimeric G protein Gs. A Gs-binding nanobody (red) binds the G protein between the a and b subunits. The nanobody (Nb35) facilitates crystallization, as does T4 lysozyme (magenta) fused to the amino terminus of the b 2 AR. c, The biological complex omitting crystallization aids, showing its location and orientation within a cell membrane.
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are in the carboxy-terminal a helix. The structural basis for G protein coupling specificity must therefore involve more subtle features of the secondary and tertiary structure. Nevertheless, a noteworthy interaction involves Phe 139, which is located at the beginning of the ICL2 helix and sits in a hydrophobic pocket formed by Gas His 41 at the beginning of the b1-strand, Val 217 at the start of the b3-strand and Phe 376, Cys 379, Arg 380 and Ile 383 in the a5-helix (Fig. 4c ). The b 2 AR mutant F139A has severely impaired coupling to Gs 19 . The residue corresponding to Phe 139 is a Phe or Leu on almost all Gs coupled receptors, but is more variable in GPCRs known to couple to other G proteins. Of interest, the ICL2 helix is stabilized by an interaction between Asp 130 of the conserved DRY sequence and Tyr 141 in the middle of the ICL2 helix ( Fig. 4c ). Tyr 141 has been shown to be a substrate for the insulin receptor tyrosine kinase 20 ; however, the functional significance of this phosphorylation is currently unknown.
The lack of direct interactions between the b 2 AR and Gbc is somewhat unexpected given that a heterotrimer is required for efficient coupling to a GPCR. Whereas Gb does not interact directly with the b 2 AR, it has an indirect but important role in coupling by stabilizing the amino-terminal a helix of Gas (Fig. 2c ). Several models involving GPCR dimers propose that one of the protomers interacts predominantly with Ga while the other interacts with Gbc [21] [22] [23] . Consistent with these models, biochemical and biophysical evidence suggests that Gai2 forms a stable complex with a LTB4 receptor dimer 24 . 
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Whereas the b 2 AR efficiently activates Gs as a monomer, extensive biochemical and biophysical evidence supports the existence of b 2 AR dimers or oligomers in living cells 25 . Therefore, we cannot exclude the possibility that in cell membranes one protomer of a b 2 AR dimer may interact with the Gbc subunit.
Structure of activated Gs
The most surprising observation in the b 2 AR-Gs complex is the large displacement of the GasAH relative to GasRas (an approximately 127u rotation about the junction between the domains) ( Fig. 5a ). GasAH moves as a rigid body as shown by the alignment of b 2 AR-Gs with GasAH from the crystal structure of Gas-GTPcS 26 ( Supplementary  Fig. 4 ). In the structure of Gas-GTPcS, the nucleotide-binding pocket is formed by the interface between GasRas and GasAH. Guanine nucleotide binding stabilizes the interaction between these two domains. The loss of this stabilizing effect of guanine nucleotide binding is consistent with the high flexibility observed for GasAH in single particle electron microscopy analysis of the detergent-solubilized complex 34 . It is also in agreement with the increase in deuterium exchange at the interface between these two domains upon formation of the complex 35 . Recently double electron-electron resonance (DEER) spectroscopy was used to document large (up to 20 Å ) changes in distance between nitroxide probes positioned on the Ras and a-helical domains of Gi upon formation of a complex with light-activated rhodopsin 27 . Finally, it has been shown that GasRas and GasAH can form a functional GTPase when expressed together as separate proteins 28 . Therefore, it is perhaps not surprising that GasAH is displaced relative to GasRas; however, its location in this crystal structure most probably reflects only one of an ensemble of conformations that it can adopt under physiological conditions, but has been stabilized by crystal packing interactions ( Supplementary Fig. 5) .
A potential concern is that Nb35, which was used to facilitate crystallogenesis, may be responsible for the displacement of the GasAH. However, Nb35, which binds at the interface between Gb and GasRas ( Fig. 2b and Supplementary Fig. 6 ), would not be expected to interact with the GasAH or interfere with its interactions with GasRas. None of the Nb35 contacts on the Ras domain are involved in interactions with GasAH on the basis of the crystal structure of Gas-GTPcS (1AZT). Moreover, if we superimpose the structures of the Ras domains of Gas-GTPcS (1AZT) and b 2 AR-Gs, there is no overlap between Nb35 and the a-helical domain of Gas-GTPcS ( Supplementary Fig. 6 ). Similarly, if we align the Gb subunits of the Gi-GDP heterotrimer (1GP2) with that of b 2 AR-Gs, there is no overlap between Nb35 and the a-helical domain of Gi ( Supplementary Fig. 6 ). This analysis is in agreement with single particle electron microscopy studies which provide further evidence that Nb35 does not disrupt interactions between GasAH and GasRas 34 .
The conformational links between the b 2 AR and the nucleotidebinding pocket primarily involve the amino-and carboxy-terminal helices of Gas (Fig. 4) . Figure 5b focuses on the region of GasRas that undergoes the largest conformational change when comparing the structure of GasRas from the b 2 AR-Gs complex with that from the Gas-GTPcS complex 26 . The largest difference is observed for the a5helix, which is displaced 6 Å towards the receptor and rotated as the carboxy-terminal end projects into transmembrane core of the b 2 AR. Previous studies using a variety of approaches have demonstrated the important role of the a5-helix in GPCR-G protein interactions 29, 30 . Associated with movement of the a5-helix, the b6-a5 loop, which interacts with the guanine ring in the Gas-GTPcS structure, is displaced outward, away from the nucleotide-binding pocket ( Fig. 5b-d) .
The movement of the a5-helix is also associated with changes in interactions between this helix and the b6-strand, the aN-b1 loop, and the a1-helix. The b1-strand forms another link between the b 2 AR and the nucleotide-binding pocket. The carboxy-terminal end of this strand changes conformation around Gly 47, and there are further changes in the b1-a1 loop (P-loop) that coordinates the b-phosphate in the GDP and GTP-bound forms ( Fig. 5b-d) . The observations in the crystal structure are in agreement with deuterium exchange experiments where there is enhanced deuterium exchange in the b1-strand and the amino-terminal end of the a5-helix upon formation of the nucleotide-free b 2 AR-Gs complex 35 . The deuterium exchange-mass spectrometry (DXMS) studies provide additional insights into the dynamic nature of these conformational changes in Gs upon complex formation 35 .
The structure of a GDP-bound Gs heterotrimer has not been determined, so it is not possible to directly compare the Gas-Gbc interface before and after formation of the b 2 AR-Gs complex. On the basis of the structure of the GDP-bound Gi heterotrimer 31 , we do not observe large changes in interactions between GasRas and Gbc upon formation of the complex with b 2 AR. This is also consistent with deuterium exchange studies 35 . As discussed above, Nb35 binds at the interface between GasRas and Gb (Fig. 2b) ; therefore, we cannot exclude the possibility that Nb35 may influence the relative orientation of the GasRas-Gbc interface in the crystal structure. 
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Assembly of the b 2 AR-Gs complex Clues to the initial stages of complex formation may come from the recent active state structures of rhodopsin 32, 33 . Figure 6a , b compares the active-state structure of b 2 AR in the b 2 AR-Gs complex with the recent structure of metarhodopsin II bound to a peptide representing the carboxy terminus of transducin 32 . The conformational changes in TM5 and TM6 are smaller in metarhodopsin II, and the position of the carboxy-terminal a helix of transducin is tilted by approximately 30u relative to the position of the homologous region of Gs. These may represent fundamental differences in the receptor-G protein interactions between these two proteins, but given the conservation of the G-protein binding pocket, the changes more probably reflect the more extensive contacts formed with the intact G protein. The position of the transducin peptide in metarhodopsin II may represent the initial interaction between a GDP-bound G protein and a GPCR. We have attempted to reproduce a similar complex between the b 2 AR and a synthetic peptide representing the carboxy-terminal 20 amino acids of Gs, but did not observe any effect of this peptide on receptor function, possibly due to the solubility and behaviour of the peptide in solution. However, when the carboxy-terminal 20 amino acids of Gs are fused to the carboxy terminus of the b 2 AR (Fig. 6c ), we observe a 27-fold increase in agonist affinity (Fig. 6d ). This effect is only 3.5-fold smaller than the effect we observe on agonist binding affinity in the b 2 AR-Gs complex, and demonstrates that there is a functional interaction between the peptide and receptor that may represent an initial stage in b 2 AR-Gs complex formation. Figure 6e and f presents a possible sequence of interactions of b 2 AR and Gs when forming the nucleotide-free complex. The first interaction of the b 2 AR with the Gs heterotrimer would require a movement of the carboxy terminus of the a5-helix away from the b6-strand to permit interactions with the b 2 AR similar to those observed in metarhodopsin II (Fig. 6e ). The availability of the carboxy terminus of the a5-helix for interactions with the b 2 AR is supported by deuterium exchange studies 35 showing that this segment is more dynamic in the Gs-GDP heterotrimer than would be expected from the crystal structure of Gas 26 . The subsequent formation of more extensive interactions between the b 2 AR ICL2 and the amino terminus of Gas requires a rotation of GasRas relative to the receptor and would be associated with further conformational changes in both b 2 AR and GasRas (Fig. 6f ). We cannot say when GDP is released during the formation of the complex; however, we speculate that uncoupling of the GasAH from GasRas is a consequence of nucleotide release or at least a coincident event. This binding model is in agreement with deuterium exchange experiments 35 .
The b 2 AR-Gs complex crystal structure provides the first highresolution view of transmembrane signalling for a GPCR. We now have a framework to design experiments to investigate the mechanism of complex formation, GTP binding and complex dissociation. Of particular interest will be studies designed to determine the functional significance of the large movement of GasAH relative to GasRas that is observed in the b 2 AR-Gs complex. A better understanding of the structural basis for G protein activation may provide new approaches for drug discovery. The high degree of structural homology within the ligand-binding pocket has posed challenges for developing highly selective drugs for specific GPCR targets. In contrast, there is relatively low homology at the interface between the b 2 AR and Gas, so identifying sequence and structural features that define specificity for particular G proteins may enable the development of selective inhibitors of specific GPCR-G protein interactions.
METHODS SUMMARY
The b 2 AR-Gs complex was crystallized from b 2 AR and Gs protein expressed in insect cells. Crystallogenesis was aided by fusing T4 lysozyme to the amino terminus of the b 2 AR and the addition of a nanobody (Nb35) that binds at the interface between the Ga and Gb subunits. Crystals were grown in a LCP using 7.7 MAG, a lipid that accommodates membrane proteins with larger hydrophilic surfaces 15 . Diffraction data were measured at beamline 23ID-B of the Advanced Photon Source and the structure was solved by molecular replacement. For more experimental details see Methods. 
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METHODS
Expression and purification of b 2 AR, Gs heterotrimer and nanobody-35. An amino-terminally fused T4 lysozyme-b 2 AR construct with b 2 AR truncated in position 365 (T4L-b 2 AR, described in detail below) was expressed in Sf9 insect cell cultures infected with recombinant baculovirus (BestBac, Expression Systems), and solubilized in n-dodecyl-b-D-maltoside (DDM) according to methods described previously 36 (see Supplementary Fig. 7 for purification overview). A b 2 AR construct truncated after residue 365 (b 2 AR-365) was used for the majority of the analytical experiments. M1 Flag affinity chromatography (Sigma) served as the initial purification step followed by alprenolol-Sepharose chromatography for selection of functional receptor. A subsequent M1 Flag affinity chromatography step was used to exchange receptor-bound alprenolol for high-affinity agonist BI-167107. The agonist-bound receptor was eluted, dialysed against buffer (20 mM HEPES, pH 7.5, 100 mM NaCl, 0.1% DDM and 10 mM BI-167107), treated with lambda phosphatase (New England Biolabs), and concentrated to approximately 50 mg ml 21 with a 50 kDa molecular weight cut off (MWCO) Millipore concentrator. Prior to spin concentration, the b 2 AR-365 construct, but not T4L-b 2 AR, was treated with PNGaseF (New England Biolabs) to remove amino-terminal amino-linked glycosylation. The purified receptor was routinely analysed by SDS-PAGE/Coomassie brilliant blue staining (see Supplementary Fig. 8a) .
Bovine Gas short, His 6 -rat Gb 1 and bovine Gc 2 were expressed in HighFive insect cells (Invitrogen) grown in Insect Xpress serum-free media (Lonza). Cultures were grown to a density of 1.5 million cells per ml and then infected with three separate Autographa californica nuclear polyhedrosis viruses each containing the gene for one of the G protein subunits at a 1:1 multiplicity of infection (the viruses were a gift from A. Gilman). After 40-48 h of incubation the infected cells were harvested by centrifugation and resuspended in 75 ml lysis buffer (50 mM HEPES, pH 8.0, 65 mM NaCl, 1.1 mM MgCl 2 , 1 mM EDTA, 13 PTT (35 mg ml 21 phenylmethanesulphonyl fluoride, 32 mg ml 21 tosyl phenylalanyl chloromethyl ketone, 32 mg ml 21 tosyl lysyl chloromethyl ketone), 13 LS (3.2 mg ml 21 leupeptin and 3.2 mg ml 21 soybean trypsin inhibitor), 5 mM b-mercaptoethanol (b-ME), and 10 mM GDP) per litre of culture volume. The suspension was pressurized with 600 p.s.i. N 2 for 40 min in a nitrogen cavitation bomb (Parr Instrument Company). After depressurization, the lysate was centrifuged to remove nuclei and unlysed cells, and then ultracentrifuged at 180,000g for 40 min. The pelleted membranes were resuspended in 30 ml wash buffer (50 mM HEPES, pH 8.0, 50 mM NaCl, 100 mM MgCl 2, 13 PTT, 13 LS, 5 mM b-ME, 10 mM GDP) per litre culture volume using a Dounce homogenizer and centrifuged again at 180,000g for 40 min. The washed pellet was resuspended in a minimal volume of wash buffer and flash-frozen with liquid nitrogen.
The frozen membranes were thawed and diluted to a total protein concentration of 5 mg ml 21 with fresh wash buffer. Sodium cholate detergent was added to the suspension at a final concentration of 1.0%, MgCl 2 was added to a final concentration of 5 mM, and 0.05 mg of purified protein phosphatase 5 (prepared in house) was added per litre of culture volume. The sample was stirred on ice for 40 min, and then centrifuged at 180,000g for 40 min to remove insoluble debris. The supernatant was diluted fivefold with Ni-NTA load buffer (20 mM HEPES, pH 8.0, 363 mM NaCl, 1.25 mM MgCl 2 , 6.25 mM imidazole, 0.2% Anzergent 3-12, 13 PTT, 13 LS, 5 mM b-ME, 10 mM GDP), taking care to add the buffer slowly to avoid dropping the cholate concentration below its critical micelle concentration too quickly. Ni-NTA resin (3 ml; Qiagen) pre-equilibrated in Ni-NTA wash buffer 1 (20 mM HEPES, pH 8.0, 300 mM NaCl, 2 mM MgCl 2 , 5 mM imidazole, 0.2% cholate, 0.15% Anzergent 3-12, 13 PTT, 13 LS, 5 mM b-ME, 10 mM GDP) per litre culture volume was added and the sample was stirred on ice for 20 min. The resin was collected into a gravity column and washed with 43 column volumes of Ni-NTA wash buffer 1, Ni-NTA wash buffer 2 (20 mM HEPES, pH 8.0, 50 mM NaCl, 1 mM MgCl 2 , 10 mM imidazole, 0.15% Anzergent 3-12, 0.1% DDM, 13 PTT, 13 LS, 5 mM b-ME, 10 mM GDP), and Ni-NTA wash buffer 3 (20 mM HEPES, pH 8.0, 50 mM NaCl, 1 mM MgCl 2 , 5 mM imidazole, 0.1% DDM, 13 PTT, 13 LS, 5 mM b-ME, 10 mM GDP). The protein was eluted with Ni-NTA elution buffer (20 mM HEPES, pH 8.0, 40 mM NaCl, 1 mM MgCl 2 , 200 mM imidazole, 0.1% DDM, 13 PTT, 13 LS, 5 mM b-ME, 10 mM GDP). Protein-containing fractions were pooled and MnCl 2 was added to a final concentration of 100 mM. Purified lambda protein phosphatase (50 mg; prepared in house) was added per litre of culture volume and the eluate was incubated on ice with stirring for 30 min. The eluate was passed through a 0.22-mm filter and loaded directly onto a MonoQ HR 16/10 column (GE Healthcare) equilibrated in MonoQ buffer A (20 mM HEPES, pH 8.0, 50 mM NaCl, 100 mM MgCl 2 , 0.1% DDM, 5 mM b-ME, 13 PTT). The column was washed with 150 ml buffer A at 5 ml min 21 and bound proteins were eluted over 350 ml with a linear gradient up to 28% MonoQ buffer B (same as buffer A except with 1 M NaCl). Fractions were collected in tubes spotted with enough GDP to make a final concentration of 10 mM. The Gs-containing fractions were concentrated to 2 ml using a stirred ultrafiltration cell (Amicon) with a 10-kDa nominal molecular weight limit (NMWL) regenerated cellulose membrane (Millipore). The concentrated sample was run on a Superdex 200 prep grade XK 16/70 column (GE Healthcare) equilibrated in S200 buffer (20 mM HEPES, pH 8.0, 100 mM NaCl, 1.1 mM MgCl 2 , 1 mM EDTA, 0.012% DDM, 100 mM TCEP, 2 mM GDP). The fractions containing pure Gs were pooled, glycerol was added to 10% final concentration, and then the protein was concentrated to at least 10 mg ml 21 using a 30 kDa MWCO centrifugal ultrafiltration device (Millipore). The concentrated sample was then aliquoted, flash frozen, and stored at 280 uC. A typical yield of final, purified Gs heterotrimer from 8 l of cell culture volume was 6 mg.
Nanobody-35 (Nb35) was expressed in the periplasm of E. coli strain WK6, extracted, and purified by nickel affinity chromatography according to previously described methods 12 followed by ion-exchange chromatography ( Supplementary  Fig. 9a ) using a Mono S 10/100 GL column (GE Healthcare). Selected Nb35 fractions were dialysed against buffer (10 mM HEPES, pH 7.5, 100 mM NaCl) and concentrated to approximately 65 mg ml 21 with a 10 kDa MWCO Millipore concentrator. Complex formation, stabilization and purification. Formation of a stable complex (see Supplementary Fig. 10 ) was accomplished by mixing Gs heterotrimer at approximately 100 mM concentration with BI-167107-bound T4L-b 2 AR (or b 2 AR-365) in molar excess (approximately 130 mM) in 2 ml buffer (10 mM HEPES, pH 7.5, 100 mM NaCl, 0.1% DDM, 1 mM EDTA, 3 mM MgCl 2 , 10 mM BI-167107) and incubating for 3 h at room temperature. BI-167107, which was identified from screening and characterizing approximately 50 different b 2 AR agonists (data not shown), has a dissociation half-time of approximately 30 h, providing a higher degree of stabilization to the active G protein-bound receptor than other full agonists such as isoproterenol 12 . To maintain the high-affinity nucleotide-free state of the complex, apyrase (25 mU ml 21 , NEB) was added after 90 min to hydrolyse residual GDP released from Gas upon binding to the receptor. GMP resulting from hydrolysis of GDP by apyrase has very poor affinity for the G protein in the complex. Rebinding of GDP can cause dissociation of the b 2 AR-Gs complex ( Supplementary Fig. 1a ).
The b 2 AR-Gs complex in DDM shows significant dissociation after 48 h at 4 uC ( Supplementary Fig. 11a ). We screened and characterized over 50 amphiphiles (data not shown) and identified MNG-3 (refs 12, 13; NG-310, Affymetrix-Anatrace) and its closely related analogues as detergents that substantially stabilize the complex ( Supplementary Fig. 11a ). The complex was exchanged into MNG-3 by adding the b 2 AR-Gs mixture (2 ml) to 8 ml buffer (20 mM HEPES, pH 7.5, 100 mM NaCl, 10 mM BI-167107) containing 1% MNG-3 for 1 h at room temperature.
At this stage the mixture contains the b 2 AR-Gs complex, non-functional Gs, and an excess of b 2 AR. To separate functional b 2 AR-Gs complex from nonfunctional Gs, and to complete the detergent exchange, the b 2 AR-Gs complex was immobilized on M1 Flag resin and washed in buffer (20 mM HEPES, pH 7.5, 100 mM NaCl, 10 mM BI-167107, and 3 mM CaCl 2 ) containing 0.2% MNG-3. To prevent cysteine bridge-mediated aggregation of b 2 AR-Gs complexes, 100 mM TCEP was added to the eluted protein before concentrating it with a 50 kDa MWCO Millipore concentrator. Of note, it was discovered later that crystal growth improved at even higher TCEP concentrations (above 1 mM) compared to 100 mM TCEP, and that the integrity of the b 2 AR-Gs complex in MNG-3 was stable to 10 mM TCEP as measured by gel filtration analysis ( Supplementary Fig. 12 ). In contrast, DDM-solubilized b 2 AR loses its ability to bind the high-affinity antagonist [ 3 H]dihydroalprenolol ([ 3 H]DHA) in 10 mM TCEP (data not shown), probably due to disruption of extracellular disulphide bonds. Iodoacetamide could not be used to block reactive cysteines on Gs a and b subunits as it caused dissociation of the b 2 AR-Gs complex ( Supplementary Fig. 12b ). The final size exclusion chromatography procedure to separate excess free receptor from the b 2 AR-Gs complex ( Supplementary Fig. 8b ) was performed on a Superdex 200 10/ 300 GL column (GE Healthcare) equilibrated with buffer containing 0.02% MNG-3, 10 mM HEPES, pH 7.5, 100 mM NaCl, 10 mM BI-167107 and 100 mM TCEP. Peak fractions were pooled ( Supplementary Fig. 8b ) and concentrated to approximately 90 mg ml 21 with a 100 kDa MWCO Viva-spin concentrator and analysed by SDS-PAGE/Coomassie brilliant blue staining ( Supplementary Fig. 8a ) and gel filtration ( Supplementary Fig. 8c ). To confirm a pure, homogeneous and dephosphorylated preparation, the b 2 AR-Gs complex was routinely analysed by ion exchange chromatography ( Supplementary Fig. 8d ). Protein engineering. To increase the probability of obtaining crystals of the b 2 AR-Gs complex we set out to increase the polar surface area on the extracellular side of the receptor using two strategies. The first approach, to generate extracellular binding antibodies, was not successful. The second approach was to replace the flexible and presumably unstructured amino terminus with the globular protein T4 lysozyme (T4L) used previously to crystallize and solve the carazolol-bound receptor 3 The construct used here (T4L-b 2 AR) contained the RESEARCH ARTICLE cleavable signal sequence followed by the M1 Flag epitope (DYKDDDDA), the Tobacco etch virus (TEV) protease recognition sequence (ENLYFQG), bacteriophage T4 lysozyme from N2 through Y161 including C54T and C97A mutations, and a two residue alanine linker fused to the human b 2 AR sequence D29 through G365. The PNGaseF-inaccessible glycosylation site of the b 2 AR at N187 was mutated to Glu. M96 and M98 in the first extracellular loop were each replaced by Thr to increase the otherwise low expression level of T4L-b 2 AR. The threonine mutations did not affect ligand binding affinity for [ 3 H]DHA, but caused a small, approximately twofold decrease in affinity for isoproterenol (data not shown).
The b 2 AR-Gs peptide fusion construct used for [ 3 H]DHA competition binding with isoproterenol was constructed from the receptor truncated at position 365 and fused to the last 21 amino acids of the Gas subunit (amino acids 374-394, except for C379A). A Gly-Ser is inserted between the receptor and the peptide. Also an extended TEV protease site (SENLYFQGS) was introduced in the b 2 AR between G360 and G361. Stabilization of Gs with nanobodies. From negative stain electron microscopy imaging 34 , we observed that the a-helical domain of Gas was flexible and therefore possibly responsible for poor crystal quality. Targeted stabilization of this domain was addressed by immunizing two llamas (Lama glama) with the bis(sulphosuccinimidyl)glutarate (BS2G, Pierce) cross-linked b 2 AR-Gs-BI-167107 ternary complex. Peripheral blood lymphocytes were isolated from the immunized animals to extract total RNA, prepare cDNA and construct a Nanobody phage display library according to published methods 16 . Nb35 and Nb37 were enriched by two rounds of biopanning on the b 2 AR-Gs-BI-167107 ternary complex embedded in biotinylated high-density lipoprotein particles 37 . Nb35 and Nb37 were selected for further characterization because they bind the b 2 AR-Gs-BI-167107 ternary complex but not the free receptor in an ELISA assay. Nanobody binding to the b 2 AR-Gs complex was confirmed by size exclusion chromatography ( Supplementary Fig. 1d ), and it was noted that both nanobodies protected the complex from dissociation by GTPcS, suggestive of a stabilizing Gs-Nb interaction ( Supplementary Fig. 1d ). Crystallization. BI-167107 bound T4L-b 2 AR-Gs complex and Nb35 were mixed in 1:1.2 molar ratio. The small molar excess of Nb35 was verified by analytical gel filtration (see Supplementary Fig. 9b ). The mixture incubated for 1 h at room temperature before mixing with 7.7 MAG (provided by M. Caffrey) containing 10% cholesterol (C8667, Sigma) in 1:1 protein solution to lipid ratio (w/w) using the twin-syringe mixing method reported previously 38 . The concentration of T4Lb 2 AR-Gs-Nb35 complex in 7.7 MAG was approximately 25 mg ml 21 . We believe the detergent MNG-3 stabilizes the T4L-b 2 AR-Gs complex during its incorporation into the lipid cubic phase. This may be due to the high affinity of MNG-3 for the receptor. The b 2 AR in MNG-3 maintains its structural integrity even when diluted below the CMC of the detergent, in contrast to b 2 AR in DDM, which rapidly loses binding activity ( Supplementary Fig. 11b ). Moreover, MNG-3 improved crystal size and quality, as previously reported 12, 13, 39 . The protein:lipid mixture was delivered through an LCP dispensing robot (Gryphon, Art Robbins Instruments) in 40 nl drops to either 24-well or 96-well glass sandwich plates and overlaid en-bloc with 0.8 ml precipitant solution. Multiple crystallization leads were initially identified using in-house screens partly based on reagents from the StockOptions Salt kit (Hampton Research). Crystals for data collection were grown in 18 to 22% PEG 400, 100 mM MES, pH 6.5 ( Supplementary Fig. 1c ), 350 to 450 mM potassium nitrate, 10 mM foscarnet ( Supplementary Fig. 1b ), 1 mM TCEP ( Supplementary Fig. 12c ), and 10 mM BI-167107. Crystals reached full size within 3-4 days at 20 uC and were picked from a sponge-like mesophase and flashfrozen in liquid nitrogen without additional cryoprotectant. Microcrystallography data collection and processing. Diffraction data were measured at the Advanced Photon Source beamline 23 ID-B. Hundreds of crystals were screened, and a final data set was compiled using diffraction wedges of typically 10 degrees from 20 strongly diffracting crystals (Supplementary Table  2 ). All data reduction was performed using HKL2000 (ref. 40) . Although in many cases diffraction to beyond 3 Å was seen in initial frames, radiation damage and anisotropic diffraction resulted in low completeness in higher resolution shells. Analysis of the final data set by the UCLA diffraction anisotropy server 41 indicated that diffraction along the a* axis was superior to that in other directions. On the basis of an F/s(F) cutoff of 3 along each reciprocal space axis, reflections were subjected to an anisotropic truncation with resolution limits of 2.9, 3.2 and 3.2 Å along a*, b* and c* before use in refinement. We report this structure to an overall resolution of 3.2 Å . Despite the low completeness in the highest resolution shells ( Supplementary Table 3 ) inclusion of these reflections gave substantial improvements in map quality and lower R free during refinement. Structure solution and refinement. The structure was solved by molecular replacement using Phaser 42, 43 . The order of the molecular replacement search was found to be critical in solving the structure. In order, the search models used were: the b and c subunits from a Gi heterotrimer (PDB ID: 1GP2), the Gs a Raslike domain (PDB ID: 1AZT), the active-state b 2 AR (PDB ID: 3P0G), a b 2 ARbinding nanobody (PDB ID: 3P0G), T4 lysozyme (PDB ID: 2RH1), and the Gs a-helical domain (PDB ID: 1AZT). Following the determination of the initial structure by molecular replacement, rigid body refinement and simulated annealing were performed in Phenix 44 and BUSTER 45 , followed by restrained refinement and manual rebuilding in Coot 46 . After iterative refinement and manual adjustments, the structure was refined in CNS using the DEN method 47 . Although the resolution of this structure exceeds that for which DEN is typically most useful, the presence of several poorly resolved regions indicated that the incorporation of additional information to guide refinement could provide better results. The DEN reference models used were those used for molecular replacement, with the exception of NB35, which was well ordered and for which no higher resolution structure is available. Side chains were omitted from 53 residues for which there was no electron density past Cb below a low contour level of 0.7s in a 2Fo 2 Fc map. Figures were prepared using PyMOL (The PyMOL Molecular Graphics System, Version 1.3, Schrödinger, LLC.). MolProbity was used to determine Ramachandran statistics 48 . Competition binding. Membranes expressing the b 2 AR or the b 2 AR-Gs peptide fusion were prepared from baculovirus-infected Sf9 cells and [ 3 H]DHA-binding performed as previously described 49 . For competition binding, membranes were incubated with [ 3 H]DHA (1.1 nM final) and increasing concentrations of (2)isoproterenol for 1 h before harvesting onto GF/B filters. Competition data were fitted to a two-site binding model and isoproterenol high and low K i values and fractions calculated using GraphPad prism.
